Quinagolide hydrochloride - Hyperprolactinaemia
You are here : Home > Formulary Search > Quinagolide hydrochloride - Hyperprolactinaemia
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Quinagolide hydrochloride
Indication :
Hyperprolactinaemia
Group Name :
Keywords :
hyperprolactinaemic disorders
Brand Names Include :
Important Information :
Quinagolide tablets are scheduled for discontinuation between December 2026 and February 2027.
Clinicians are advised not to start new patients on this treatment. Existing patients may require specialist advice in relation to suitable alternatives
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Committee Recommendations (0)
- No records returned.
Other Indications
Below are listed other indications that Quinagolide hydrochloride is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Hyperprolactinaemia.